PubRank

A Vitali

Author PubWeight™ 38.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A 1998 4.48
2 Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 1999 1.94
3 Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci U S A 1999 1.51
4 Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet 2000 1.25
5 Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment. Neurology 2004 1.23
6 Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine. Tumour Biol 1996 1.16
7 Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun 2000 1.14
8 Intestinal localization of anisakiasis manifested as acute abdomen. Clin Microbiol Infect 2003 1.13
9 A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability. J Biol Chem 1999 1.10
10 Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase. Biochem Pharmacol 2006 1.07
11 [2 cases of death caused by hepatic insufficiency after jejuno-ileal bypass for obesity]. Minerva Chir 1980 0.96
12 A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer's disease. Neurol Sci 2005 0.95
13 Regulation of rat hepatocyte protein kinase C beta isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: A signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 1999 0.94
14 Molecular cloning and chromosomal localisation of the human homologue of a receptor related to tyrosine kinases (RYK). Oncogene 1993 0.91
15 Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop. Tumour Biol 1996 0.89
16 Aryltetralin lignans: chemistry, pharmacology and biotransformations. Curr Med Chem 2001 0.87
17 Ethanol-induced effects on expression level, activity, and distribution of protein kinase C isoforms in rat liver Golgi apparatus. Chem Biol Interact 1998 0.86
18 Glutathione depletion induces apoptosis of rat hepatocytes through activation of protein kinase C novel isoforms and dependent increase in AP-1 nuclear binding. Free Radic Biol Med 2000 0.86
19 Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: a preliminary report. Oral Dis 2005 0.85
20 Comparison between metabolite productions in cell culture and in whole plant of Maclura pomifera. Phytochemistry 1995 0.83
21 Carbamazepine plasma levels in children and adults: influence of age, dose, and associated therapy. Ther Drug Monit 1980 0.83
22 Does transurethral thermotherapy induce a long-term alpha blockade? An immunohistochemical study. Eur Urol 1993 0.83
23 Tanycytic ependymoma of the spinal cord. Case report and review of the literature. Neurochirurgie 2003 0.82
24 Dorfman-Chanarin syndrome: a case with prevalent hepatic involvement. J Hepatol 1996 0.81
25 Structural and functional characterization of the porcine proline-rich antifungal peptide SP-B isolated from salivary gland granules. J Pept Sci 2008 0.80
26 Determination of the post-translational modifications of salivary acidic proline-rich proteins. Eur J Morphol 2003 0.80
27 Two proline-rich peptides from pig (Sus scrofa) salivary glands generated by pre-secretory pathway underlying the action of a proteinase cleaving ProAla bonds. Peptides 2005 0.80
28 The 3T3-L1 fibroblast to adipocyte conversion is accompanied by increased expression of angiopoietin-1, a ligand for tie2. Growth Factors 2000 0.79
29 Examining structured representation and designated fiscal support for women's health in the U.S. Department of Health and Human Resources. J Womens Health Gend Based Med 2001 0.78
30 Neurosurgical treatment of tremor in anti-myelin-associated glycoprotein neuropathy. Neurology 2009 0.78
31 Mechanisms of inactivation of hepatocyte protein kinase C isoforms following acute ethanol treatment. Free Radic Biol Med 1998 0.78
32 Lymphoblastoid interferon therapy in chronic hepatitis C: biochemical, virological and histological evaluation of two different doses. Liver 1995 0.78
33 Temperature humidity index scenarios in the Mediterranean basin. Int J Biometeorol 2012 0.77
34 Different structural behaviors evidenced in thaumatin-like proteins: a spectroscopic study. Protein J 2008 0.77
35 Results of rebiopsy for suspected prostate cancer in symptomatic men with elevated PSA levels. Eur Urol 1997 0.77
36 Primary role of alcohol dehydrogenase pathway in acute ethanol-induced impairment of protein kinase C-dependent signaling system. Adv Exp Med Biol 1999 0.77
37 Synthesis and biosynthesis of isocordoin. Planta Med 2001 0.77
38 Effects of sublethal doses of silver nanoparticles on Bacillus subtilis planktonic and sessile cells. J Appl Microbiol 2015 0.77
39 [The involvement of the urinary tract in inguinal hernias]. Ann Ital Chir 1999 0.76
40 Malignant priapism due to a huge renal carcinoma. Eur Urol 1992 0.75
41 Papnet-assisted cytological diagnosis intensifies the already marked variability among cytological laboratories. Eur J Gynaecol Oncol 2002 0.75
42 [Ischemic pathogenesis of acute pancreatitis. A case report]. Minerva Chir 2000 0.75
43 [Verapamil in the cardioversion of atrial fibrillation. Clinical study]. Minerva Cardioangiol 2003 0.75
44 [Diagnostic efficiency of dynamic electrocardiographic monitoring by the Holter method in the study of patients with syncope or minor equivalents]. Minerva Cardioangiol 1987 0.75
45 [Neurological and electroencephalographic problems in determining brain death in organ donors]. Minerva Med 1974 0.75
46 [Colo-uterine fistula, a complication of sigma diverticulitis]. Minerva Chir 1998 0.75
47 [Studies on the prevention of cerebral edema due to experimental inflammation: action of escine, sodium salt]. Riv Sper Freniatr Med Leg Alien Ment 1968 0.75
48 Parafalcine chondrosarcoma: report of a case and review of the literature. J Neurosurg Sci 2009 0.75
49 [Moiré topography in early diagnosis of scoliosis]. Arch Putti Chir Organi Mov 1984 0.75
50 [Venous perfusion with barbiturates in rapid elimination of acute anxiety states]. G Psichiatr Neuropatol 1969 0.75
51 [Urinary excretion of PGE2 and renal function in acute myocardial infarction]. Boll Soc Ital Biol Sper 1984 0.75
52 [Arrhythmia or artifact? Diagnosis is not always obvious in Holter's dynamic electrocardiography]. Minerva Cardioangiol 1989 0.75
53 Comparison between digital rectal examination, prostate-specific antigen and transrectal ultrasound in symptomatic patients. Results on 141 cases. Eur Urol 1992 0.75
54 [Epileptic crises secondary to intermittent complete atrioventricular block. Description of a case]. Minerva Cardioangiol 1988 0.75
55 [The role of endoscopy and histology in the diagnosis of esophagitis]. Minerva Chir 1980 0.75
56 [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG]. Minerva Cardioangiol 1985 0.75
57 [Sudden death during Holter electrocardiographic monitoring. Description of a case]. Minerva Cardioangiol 1986 0.75
58 [Correlations of symptoms and objective findings in dynamic electrocardiography by the Holter method: palpitations]. Minerva Cardioangiol 1987 0.75
59 [Interatrial block in acute myocardial infarction. Description of a case]. Minerva Cardioangiol 1988 0.75
60 [Reciprocating atrioventricular tachycardia caused by a re-entry circuit involving an occult left atrioventricular anomalous pathway. A possible diagnosis with surface ecg]. Minerva Cardioangiol 1988 0.75
61 [Possible pro-arrhythmic effects of vagal stimulation maneuvers]. Minerva Cardioangiol 1989 0.75
62 [Further case reports on angioplastic dysplasia: (1) esophago-gastro-enterio varicose condition; (2) esophageal varices caused by an abnormal subclavian vein; (3) hepato-adrenal angiomatous "involutive dysplasia"]. Pathologica 1975 0.75
63 [Analysis of 23 years of activity of a polyvalent resuscitation department at a clinical IRCCSS hospital: socioeconomic, ethical and organizational implications on the eve of the year 2000]. Minerva Anestesiol 1990 0.75
64 [Significance of endoscopy in the diagnosis of gastropathies and duodenogastric reflux]. Minerva Dietol Gastroenterol 1982 0.75
65 [Role of the family group in attempted suicide among the young]. Minerva Med 1977 0.75
66 [Analogies and contrasts of familial enviornment in juveniles attempting suicide and in toxicomania]. Minerva Med 1976 0.75
67 [Myelolipoma of the adrenal glands. Presentation of a clinical case and review of the literature]. Minerva Chir 1989 0.75
68 [Pharmacologic combinations in the therapy of depression: experiences with Mutabon (perphenazine and amitriptyline)]. Riv Sper Freniatr Med Leg Alien Ment 1971 0.75
69 Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency. J Endocrinol Invest 2004 0.75
70 [A variant of the Bussolati decalcificator (with an evaluation of the results obtained in 16 cases of bone marrow biopsies)]. Pathologica 1982 0.75
71 Further hypotensive metabolites from Verbesina caracasana. Bioorg Med Chem Lett 1999 0.75